Legislators and the Regulatory Order
Over the last thirty years, advanced capitalist democracies of Western Europe have seen the massive spread of independent regulatory agencies. What has been the level of implication of legislators in this process? What is their concrete involvement in the monitoring of regulatory decisions now that independent agencies are firmly entrenched in the governance of advanced economies? On the basis of this twofold research question, the project intends to characterize political-economic interdependences under regulatory capitalism, and the various forms of re/de-politicization processes they entail. Comparing France and the United Kingdom, it mixes quantitative analysis of legislative design and oversight of regulatory agencies and semi-structured interviews with regulators. The project is funded by a Fondation Nationale des Sciences Politiques – SAB Research grant for the period 2020-2022. Some motivations for this project appear in my chapter in the Handbook of Parliamentary Studies (edited with O. Rozenberg, 2020, Edward Elgar).
Solvency II, the rise of data science and the transformation of social protection
This project examines how the implementation of Solvency II and the rise of data science and data analytics are changing both insurance as an industry but more fundamentally the principles, rules and visions governing the share of social protection covered by insurance firms. Given the importance taken by the conceptions of risks, risk exposure, insurability or calculable losses as forged by the insurance industry in the development of European Welfare States, the profound changes the sector is now facing prefigure further transformations for social welfare models. Data collection involves in-depth qualitative interviews within two insurance companies. The project is funded by a grant from the Chaire PARI, a multidisciplinary research program supervised by Pierre François and Laurence Barry. More information available here. The project largely builds on my research on the political economy of (EU) insurance regulation and its implications for (domestic) social policy, that notably appears in Private Health Insurance and the European Union (edited with M. Del Sol & P. Martin, 2021, Palgrave) and in ‘Private Health Insurance in France: Between Europeanization and Collectivization’ (The Milbank Quarterly, with G. Coron).
My previous scholarship on the political economy of pharmaceutical regulation in France, the UK and the US appears in Réguler l’accès aux médicaments (PUG, 2020) and in various journal articles, including ‘Gouverning (through) prices: the State and Pharmaceutical Pricing in France’ (Revue française de Sociologie, with E. Nouguez); ‘Le pouvoir de régulation transnational d’une agence nationale’ (Gouvernement & Action Publique) and ‘Health Technology Assessment: the Scientific Career of a Policy Concept (International Journal of Technology Assessment in HealthCare, with P. Gorry).